Home / Medroxyprogesterone / Belgium
BE ATC G03DA02 · updated 4 Nov 2026
Medroxyprogesterone shortage in Belgium
Is there a Medroxyprogesterone shortage in Belgium?
Yes. As of 4 Nov 2026, 1 Medroxyprogesterone product is reported short in Belgium. The company estimate for the return is 11 Dec 2026. Main reason: manufacturing problem.
Also short in Canada. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Provera 400 mg tabl. 25 anticipated | Pfizer | 18 Nov 2026 | 11 Dec 2026 | Manufacturing problem Delay in production |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.